The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

August 10, 2023

Study Completion Date

August 10, 2023

Conditions
Vitamin B1 DeficiencyThiamine Deficiency
Interventions
DRUG

Trimethoprim

300mg of trimethoprim will be given in combination with 5mg thiamine and compared to 5mg thiamine only for both Parts 1 and 2 of the study.

DRUG

Metformin

1000mg of metformin will be given in combination with 5mg thiamine and compared to 5mg thiamine only in Part 1 of the study.

DIETARY_SUPPLEMENT

Vitamin B1

5mg of thiamine will be given alone and in combination for both Parts 1 and 2 of the study.

Trial Locations (1)

02111

Jean Mayer USDA Human Nutrition Research Center on Aging, Boston

All Listed Sponsors
collaborator

Tufts University

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

University of California, Davis

OTHER

lead

University of California, San Francisco

OTHER

NCT03746106 - The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine | Biotech Hunter | Biotech Hunter